No products in the cart.

五星推荐产品

Anti-HLA Class 1 ABC Antibody [EMR8-5] (品牌:abcam,货号:ab70328)

SKU Product Brand Unit Availability Price 促销价 Quantity  
ab70328
Anti-HLA Class 1 ABC Antibody [EMR8-5] (品牌:abcam,货号:ab70328)
abcam 100 µL In stock
6,136.00

Specifications        

Product Cat#: ab70328
Product type: Primary antibody
Antigen: HLA Class 1 ABC
Immunogen: Full length protein corresponding to HLA Class 1 ABC. Recombinant HLA-A*2402 extracellular domain.
Species immunized: Mouse
Isotype: IgG1, kappa
Applications: Flow Cyt, IHC-P, WB
Reactivity: Human
Clonality (clone number): Monoclonal, EMR8-5
Form: Liquid
Buffer: pH: 7.40, Preservative: 0.05% Sodium azide, Constituent: PBS
Concentration: 1 mg/mL
Purity: Protein A purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: Antigen Presenting Molecule antibody
Cw*1701 antibody
D6S204 antibody
FLJ27082 antibody
HLA A antibody
HLA B antibody
HLA C antibody
HLA class 1 A antibody
HLA class 1 B antibody
HLA class 1 C antibody
HLA JY3 antibody
HLAA antibody
HLAB antibody
HLAC antibody
HLC C antibody
Human Leucocyte Antigen C antibody
Major Histocompatibility Complex Class I A antibody
Major Histocompatibility Complex Class I B antibody
Major Histocompatibility Complex Class I C antibody
Major histocompatibility complex, class I, A + B + C antibody
MHC class I antigen A*1 antibody
MHC Class I Antigen antibody
MHC class I antigen B*7 antibody
MHC class I antigen Cw*1 antibody
MHC class I HLA A antibody
MHC class I HLA B antibody
MHC class I HLA C antibody
MHC HLA ABC antibody
PSORS1 antibody
展开

靶标信息

Antigen-presenting major histocompatibility complex class I (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays primarily viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-A-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected or transformed cells (PubMed:2456340, PubMed:2784196, PubMed:1402688, PubMed:7504010, PubMed:9862734, PubMed:10449296, PubMed:12138174, PubMed:12393434, PubMed:15893615, PubMed:17189421, PubMed:19543285, PubMed:21498667, PubMed:24192765, PubMed:7694806, PubMed:24395804, PubMed:28250417).
May also present self-peptides derived from the signal sequence of secreted or membrane proteins, although T cells specific for these peptides are usually inactivated to prevent autoreactivity (PubMed:25880248, PubMed:7506728, PubMed:7679507).
Both the peptide and the MHC molecule are recognized by TCR, the peptide is responsible for the fine specificity of antigen recognition and MHC residues account for the MHC restriction of T cells (PubMed:12796775, PubMed:18275829, PubMed:19542454, PubMed:28250417).
Typically presents intracellular peptide antigens of 8 to 13 amino acids that arise from cytosolic proteolysis via IFNG-induced immunoproteasome or via endopeptidase IDE/insulin-degrading enzyme (PubMed:17189421, PubMed:20364150, PubMed:17079320, PubMed:26929325, PubMed:27049119).
Can bind different peptides containing allele-specific binding motifs, which are mainly defined by anchor residues at position 2 and 9 (PubMed:7504010, PubMed:9862734).

相关文献

1、Godfrey J  et al. Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv 7:963-970 (2023).

2、Merckx C  et al. Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse. Int J Mol Sci 23:N/A (2022).

3、van der Woude LL  et al. Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination. J Immunother Cancer 10:N/A (2022).

4、Mu D  et al. Downregulation of PD-L1 and HLA-I in non-small cell lung cancer with ALK fusion. Thorac Cancer 13:1153-1163 (2022).

5、Xiong X  et al. Emerging enterococcus pore-forming toxins with MHC/HLA-I as receptors. Cell 185:1157-1171.e22 (2022).